Optimal product portfolio management is increasingly important for generic pharmaceutical companies in today’s intensely competitive environment. Strategic focus and front-level risk management are imperative for ensuring maximum value. This article addresses the key considerations and risks for ensuring a successful portfolio in a dynamic pharmaceutical landscape.
ThakurVPRamachaS. Pharmaceutical business strategy: a generics perspective. J Intellectual Property Rights2012; 17: 484–496.
3.
KakkarAK. Pateny cliff mitigation strategies: giving new life to blockbusters. Expert Opin Ther Pat2015; 25: 1353–1359.
4.
Sax F, Huml RA and Ng-Cahin J. Clinical aspects of pharmaceutical portfolio management. In: Antonijevic Z (ed.) Optimization of pharmaceutical R&D programs and portfolios: design and investment strategy (Chapter 2). Springer, 2015, pp.19–33.
5.
StevensonR. Creating real value in pharmaceuticals: driving business development through portfolio strategy. Bus Dev Licensing J2009; 7: 20–24.
6.
Bhoopathy S, Silchenko S, Wang X and Murray LJ. Strategies for the equivalence assessment of locally acting complex drug products: focus on alternative methodologies. AAPS Newsmagazine, February 2015,pp.13–16.
